Medicare to Cover FDA-Approved Alzheimer’s Drug Leqembi

  The Food and Drug Administration (FDA) has given full approval to an Alzheimer’s treatment…

Read More

FDA Approves Alzheimer’s Drug Leqembi

  On January 6, 2023, the Food and Drug Administration (FDA) approved a new Alzheimer’s…

Read More

NCMS Foundation Webinar: Treating Hepatitis C in Patients with Substance Use Disorders

    Register now for the webinar: "Treating Hepatitis C in Patients with Substance Use…

Read More